Government Makes Cough Syrups Prescription-Only; Ends Over-the-Counter Sales

The Union Ministry of Health and Family Welfare has implemented a new regulation requiring prescription from a registered medical practitioner for the purchase of all syrups, including cough syrups, ending over-the-counter sales. This regulatory change, effective immediately, addresses longstanding concerns about (1) Antibiotic resistance from indiscriminate use, (2) Abuse of codeine-based cough syrups, (3) Unregulated self-medication, (4) Public health risks from unsupervised consumption. Background: India has faced criticism for lax pharmaceutical regulation compared to international standards, particularly regarding cough syrup formulations banned in developed nations. Previous regulatory gaps led to serious public health incidents and contributed to antimicrobial resistance crisis. The policy aligns with WHO recommendations on antimicrobial stewardship. For UPSC: relevant for questions on (1) Public health governance and pharmaceutical regulation, (2) Antimicrobial resistance as a health security threat, (3) Drug regulation under Drugs and Cosmetics Act, 1940, (4) National Health Mission objectives, (5) Clinical practice standards. The measure reflects India's commitment to combating AMR, a declared health emergency. Also connects to broader health policy discussions on rational drug use and regulatory frameworks. Previous year connections to health security.